The global anticoagulants market size is expected to grow from $36.50 billion in 2021 to $40.34 billion in 2022 at a compound annual growth rate (CAGR) of 10.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The anticoagulant market is expected to reach $56.94 billion in 2026 at a CAGR of 9%.
What is the Global Anticoagulants Market?
The anticoagulants market consists of sales of anticoagulants by entities (organizations, sole traders, and partnerships) that manufacture anticoagulant drugs which keep blood vessels open and prevent the formation of blood clots. Anticoagulants are referred to as blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.
Get a Sample of the global anticoagulants market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&&type=smp
What drives the Global Anticoagulants Market?
The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Anticoagulation pharmacotherapy known as direct oral anticoagulants is used to minimize thrombosis in a variety of cardiovascular situations. According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.
Get the full global anticoagulants industry report here:
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report
Global Anticoagulants Market Segments
The global anticoagulants market is segmented:
By Drug Class: Factor Xa Inhibitor, Heparin and LMWH, Vitamin K Antagonist, Others
By Route of Administration: Oral Anticoagulant, Injectable Anticoagulant
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Application: Venous Thromboembolism, Atrial Fibrillation or Flutter, Coronary Artery Disease, Others
By End-User: Hospitals, Homecare, Specialty Centers, Others
By Geography: The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Anticoagulants Global Market Report 2022provides market size and growth forecasts for the global anticoagulants market, global anticoagulants market share, anticoagulants market segments and geographies, anticoagulants market competitive landscape including leading competitors’ revenues, profiles and market shares. The anticoagulants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Anticoagulants Industry Playersinclude GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka and Leo Pharma. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
